These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31934080)

  • 1. Diagnostic and prognostic significance of serum miR-145-5p expression in glioblastoma.
    Zhang Y; Ta WW; Sun PF; Meng YF; Zhao CZ
    Int J Clin Exp Pathol; 2019; 12(7):2536-2543. PubMed ID: 31934080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
    Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-29b as a novel biomarker for glioblastoma diagnosis and prognosis.
    Zhong F; Huang T; Leng J
    Int J Clin Exp Pathol; 2019; 12(11):4106-4112. PubMed ID: 31933806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic effect of serum miR-139-5p as an indicator in osteosarcoma.
    Zhou L; Ma X; Yue J; Chen T; Wang XY; Wang ZW; Pan J; Lin Y
    Cancer Biomark; 2018; 23(4):561-567. PubMed ID: 30347602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
    Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
    Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
    Chen J; Yang L; Wang X
    Cancer Biomark; 2017 Dec; 20(4):521-526. PubMed ID: 28946553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging role of miRNAs as liquid biopsy markers for prediction of glioblastoma multiforme prognosis.
    Swellam M; Bakr NM; El Magdoub HM; Hamza MS; Ezz El Arab LR
    J Mol Neurosci; 2021 Apr; 71(4):836-844. PubMed ID: 32989634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miR-34a is a potential diagnostic and prognostic marker for osteosarcoma.
    Wang T; Wu J; Liu X; Li S
    Int J Clin Exp Pathol; 2017; 10(9):9683-9689. PubMed ID: 31966849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic significance of serum miR-203 in patients with acute myeloid leukemia.
    Zheng Z; Rong G; Li G; Ren F; Ma Y
    Int J Clin Exp Pathol; 2019; 12(5):1548-1556. PubMed ID: 31933972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal miR-2276-5p in Plasma Is a Potential Diagnostic and Prognostic Biomarker in Glioma.
    Sun J; Sun Z; Gareev I; Yan T; Chen X; Ahmad A; Zhang D; Zhao B; Beylerli O; Yang G; Zhao S
    Front Cell Dev Biol; 2021; 9():671202. PubMed ID: 34141710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
    Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
    Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas.
    Wu J; Al-Zahrani A; Beylerli O; Sufianov R; Talybov R; Meshcheryakova S; Sufianova G; Gareev I; Sufianov A
    Front Oncol; 2022; 12():898537. PubMed ID: 35646622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of the serum miR-455-5p expression in patients with neonatal sepsis.
    Mao YY; Su C; Fang CC; Fan XP; Wang LP; Zhu SS; Yao HM
    Bioengineered; 2021 Dec; 12(1):4174-4182. PubMed ID: 34288799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.